Finance

Lists
TAKP34:BVMF
Takeda Pharmaceutical Co Ltd BDR
R$82,32
0,00%
(0,00) 1D
26 ມິ.ຖ., 13 ໂມງ 16 ນາທີ 38 ວິນາທີ GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for TAKP34...
Mkt. cap
໕໔,໓໕ ຕື້
Avg. vol.
໐,໐໐
Volume
໐,໐໐
52-wk high
R$95,30
52-wk low
R$70,80
Shares outstanding
໑,໖໐ ຕື້
No. of employees
໔໗ ພັນ
Mkt. cap
໕໔,໓໕ ຕື້
Avg. vol.
໐,໐໐
Volume
໐,໐໐
52-wk high
R$95,30
52-wk low
R$70,80
Shares outstanding
໑,໖໐ ຕື້
No. of employees
໔໗ ພັນ
News stories
From sources across the web
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd BDR
CEOChristophe Weber | Christophe Weber
Employees47 ພັນ
Founded12 ມິ.ຖ. 1781
Headquarters-
SectorPharmaceutical industry
Websitetakeda.com
Next call ໃນອີກ 6 ມື້
ພະຫັດ 30 ກ.ລ., 12:00
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
- / ໑,໑໕ ລ້ານລ້ານ
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
ມິ.ຖ. 2025
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
Revenue
1,11 ລ້ານລ້ານ
1,11 ລ້ານລ້ານ
1,19 ລ້ານລ້ານ
1,09 ລ້ານລ້ານ
Cost of goods sold
384,68 ຕື້
380,06 ຕື້
401,15 ຕື້
453,33 ຕື້
Cost of revenue
384,68 ຕື້
380,06 ຕື້
401,15 ຕື້
453,33 ຕື້
Research and development expenses
143,89 ຕື້
161,48 ຕື້
175,23 ຕື້
187,96 ຕື້
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
255,88 ຕື້
253,55 ຕື້
282,78 ຕື້
291,96 ຕື້
Operating expense
535,14 ຕື້
562,57 ຕື້
661,30 ຕື້
519,65 ຕື້
Total operating expenses
919,82 ຕື້
942,63 ຕື້
1,06 ລ້ານລ້ານ
972,98 ຕື້
Operating income
186,86 ຕື້
170,17 ຕື້
129,25 ຕື້
121,56 ຕື້
Other non operating income
-77,96 ຕື້
77,96 ຕື້
8,80 ຕື້
-24,50 ຕື້
EBT including unusual items
150,63 ຕື້
28,17 ຕື້
133,86 ຕື້
-455,02 ຕື້
EBT excluding unusual items
152,93 ຕື້
128,86 ຕື້
114,17 ຕື້
71,49 ຕື້
Income tax expense
26,35 ຕື້
39,90 ຕື້
30,13 ຕື້
-86,62 ຕື້
Effective tax rate
17,49%
141,64%
22,51%
19,04%
Other operating expenses
6,03 ຕື້
16,12 ຕື້
67,13 ຕື້
-64,27 ຕື້
Net income
124,24 ຕື້
-11,80 ຕື້
103,64 ຕື້
-368,47 ຕື້
Net profit margin
11,23%
-1,06%
8,70%
-33,66%
Earnings per share
-
-
-
-
Interest and investment income
73,76 ຕື້
43,92 ຕື້
93,00 ຕື້
17,22 ຕື້
Interest expense
-29,20 ຕື້
-161,10 ຕື້
-117,68 ຕື້
-50,82 ຕື້
Net interest expenses
44,56 ຕື້
-117,18 ຕື້
-24,68 ຕື້
-33,60 ຕື້
Depreciation and amortization charges
-
-
-
-
EBITDA
368,50 ຕື້
355,15 ຕື້
182,70 ຕື້
589,63 ຕື້
Gain or loss from assets sale
-17,32 ຕື້
303,00 ລ້ານ
358,00 ລ້ານ
1,46 ຕື້
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer